Apollo Hospitals Enterprise Q2 Results Live : Apollo Hospitals Enterprise announced its Q2 results on 06 November 2024, showcasing a significant improvement in its financial performance. The company’s revenue surged by 15.32% year-over-year (YoY), while profits saw a remarkable increase of 62.64% compared to the same quarter last year.
In comparison to the previous quarter, Apollo’s revenue grew by 9.9%, and profits increased by 24.12%, demonstrating strong sequential growth. The operating income also experienced a healthy rise, up 26.78% quarter-over-quarter (QoQ) and 35.41% YoY, reflecting effective cost management and operational efficiency.
The company’s earnings per share (EPS) reached ₹26.34 for Q2, marking a 63.47% increase YoY, a strong indicator of its profitability and operational success. Despite a slight dip of -0.21% in the last week, Apollo Hospitals has achieved impressive returns of 19.18% over the past six months and 22.16% year-to-date (YTD).
As of now, Apollo Hospitals Enterprise boasts a market capitalization of ₹100,190.6 crore, with a 52-week high of ₹7,316.95 and a low of ₹5,087.45. This strong performance has garnered positive attention from analysts, with 13 recommending a ‘Buy’ and 6 suggesting a ‘Strong Buy’ out of 24 analysts covering the company as of 07 November 2024.
The consensus recommendation remains positive, indicating a strong outlook for Apollo Hospitals Enterprise as it continues to thrive in the competitive healthcare sector.
Apollo Hospitals Enterprise Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 5589.3 | 5085.6 | +9.9% | 4846.9 | +15.32% |
| Selling/ General/ Admin Expenses Total | 700.1 | 658.1 | +6.38% | 644.1 | +8.69% |
| Depreciation/ Amortization | 184.5 | 177.4 | +4% | 163.4 | +12.91% |
| Total Operating Expense | 4958.3 | 4587.9 | +8.07% | 4380.9 | +13.18% |
| Operating Income | 631 | 497.7 | +26.78% | 466 | +35.41% |
| Net Income Before Taxes | 551.7 | 418.5 | +31.83% | 379 | +45.57% |
| Net Income | 378.8 | 305.2 | +24.12% | 232.9 | +62.64% |
| Diluted Normalized EPS | 26.34 | 21.23 | +24.07% | 16.11 | +63.47% |
